
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Denileukin Diftitox
Therapeutic Area : Oncology
Study Phase : Approved FDF
Recipient : Citius Oncology
Deal Size : Undisclosed
Deal Type : Agreement
Citius Oncology Inks U.S. Distribution Deal with McKesson for LYMPHIR Launch
Details : The agreement will support the clinical development of Denileukin Diftitox for Stage I-III cutaneous T-cell lymphoma targeting Elongation factor 2 and Interleukin-2 receptor.
Product Name : Lymphir
Product Type : Miscellaneous
Upfront Cash : Undisclosed
October 20, 2025
Lead Product(s) : Denileukin Diftitox
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Recipient : Citius Oncology
Deal Size : Undisclosed
Deal Type : Agreement

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Centers For Disease Control
Deal Size : Undisclosed
Deal Type : Collaboration
McKesson to Distribute Future COVID-19 Vaccines in Support of Operation Warp Speed
Details : McKesson Corporation will expand its existing partnership with the Centers for Disease Control (CDC) to support the U.S. government’s Operation Warp Speed team as a centralized distributor of future COVID-19 vaccines and ancillary supplies needed to ad...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
August 14, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Centers For Disease Control
Deal Size : Undisclosed
Deal Type : Collaboration
